New anemia drug gets China approval


ZHENG YIRAN Roxadustat, a domestically developed Class 1 medicine, received marketing approval from the National Medical Products Administration on Tuesday, a milestone for China’s biopharmaceutical research and development industry. AstraZeneca China...

Read latest China Daily (Canada) online.

Online newspapers at PressDisplay. Newspapers from Canada
Newspapers in English